ERVW-1 and HIV-1 infection: This review examines the adaptive immune responses triggered by HIV Env, with an emphasis on how Env glycosylation simultaneously constrains B-cell recognition and contributes to antigen processing and T-cell-mediated immune responses, aiming to lay the groundwork for future vaccine development and to inform strategies that elicit robust and lasting protection against HIV-1 infection.